<DOC>
	<DOCNO>NCT00606593</DOCNO>
	<brief_summary>A 2-night polysomnography / 5-way cross-over study evaluate effect , safety tolerability oral administration almorexant ( ACT 078573 ) elderly subject primary insomnia .</brief_summary>
	<brief_title>Almorexant ( ACT-078573 ) Elderly Subjects With Chronic Primary Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Elderly subject ( &gt; 64 year ) diagnosis primary insomnia . History sleep disorder , Diagnostic Statistical Manual Mental Disorders IV ( DSMIV ) axis I disorder primary insomnia . Sleep apnea , restless legs syndrome . Daytime nap 1 hour per day . Important caffeine consumption , heavy tobacco use , alcohol drug abuse within 2 year prior screen visit . Unwillingness refrain drug , overthecounter herbal medication effect sleep behavior .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>insomnia</keyword>
	<keyword>elderly</keyword>
	<keyword>sleeplessness</keyword>
</DOC>